$23.12 (1.72%)

Volume: 379.618k

Closed: Mar 21, 2023

Hollow Logo Score: -3.261
Agios Pharmaceuticals Stock
$23.12 (1.72%)

Volume: 379.618k

Closed: Mar 21, 2023

Score Hollow Logo -3.261
NASDAQ:AGIO

Agios Pharmaceuticals Stock Company Profile

88 Sidney Street, 2nd Floor

Cambridge MA 02139-4169

617 649 8600

www.agios.com

Industry: Biotechnology

Sector: Healthcare

Agios Pharmaceuticals

Description

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT